Impact BioMedical (IBO)
4.01
+0.21 (5.53%)
Upcoming Events
Latest Headlines
Form DEFM14A IMPACT BIOMEDICAL INC.
October 27, 2026 6:02 AM - SEC Filing
Form 8-K IMPACT BIOMEDICAL INC. For: Sep 23
October 9, 2026 4:59 PM - SEC Filing
Form 4 IMPACT BIOMEDICAL INC. For: Sep 22 Filed by: DSS, INC.
September 24, 2026 7:38 PM - SEC Filing
Form 8-K IMPACT BIOMEDICAL INC. For: Sep 16
September 17, 2026 6:02 AM - SEC Filing
Zoar files Form F-4 for Impact Biomedical business combination
September 16, 2026 9:26 AM - StreetInsider
DSS, Inc. Announces Form F-4 Filing in Connection with Impact Biomedical’s Proposed Business Combination with Zoar Limited
September 16, 2026 9:25 AM - Globe NewsWire
Impact Biomedical files Form F-4 for merger with Zoar Ltd.
September 16, 2026 9:20 AM - StreetInsider
Impact Biomedical Inc Announces Filing of Form F-4 Registration Statement in Connection with Proposed Merger with Zoar Ltd. (f/k/a Dr. Ashley’s Limited)
September 16, 2026 9:20 AM - Globe NewsWire
Form 8-K IMPACT BIOMEDICAL INC. For: Sep 14
September 15, 2026 6:14 AM - SEC Filing
Impact Biomedical sets 1-for-12.62 reverse split ahead of merger
September 14, 2026 9:27 PM - StreetInsider
CORRECTED — Impact Biomedical Inc (NYSE: IBO) Announces 1 for 12.62 Reverse Stock Split to Pursue Completion of Merger with Zoar Limited (f/k/a Dr Ashleys Limited)
September 14, 2026 9:26 PM - Globe NewsWire
Impact BioMedical announces 1-for-12.62 reverse stock split ahead of merger
September 11, 2026 4:05 PM - StreetInsider
Impact BioMedical Inc (NYSE American: IBO) Announces 1 for 12.62 Reverse Stock Split to Pursue Completion of Merger with Zoar Ltd. (previously Dr. Ashley’s Ltd.)
September 11, 2026 4:05 PM - Globe NewsWire
Form 10-Q IMPACT BIOMEDICAL INC. For: Jun 30
August 7, 2026 4:32 PM - SEC Filing
Full Article List
